Podcast Episodes
Back to SearchMidyear Review: 2026 So Far & a Look Forward
Episode 13
Wayne chats with Paul Kim, Principal of Kendall Square Policy Strategies LLC, and Dr. Susan Mayne, Adjunct Professor at the Yale School of Public He…
3 months ago
From Price Strategy to Enforcement Risk
Season 1 Episode 46
In this third and final part of our series in collaboration with White & Case and BRG, Wayne chats with Lauren Papenhausen, Partner at White & Case'…
3 months, 1 week ago
When Pricing Pressure Reaches the FDA File: Practical FDA Realities
Season 1 Episode 45
In this second part of our series in collaboration with White & Case and BRG, Wayne chats with Bethany Hills, Partner at White & Case, and Dan Troy,…
4 months ago
Governmental Policy Levers: Navigating Drug Pricing Across Agencies and Congress
Season 1 Episode 44
In this first part of our series in collaboration with White & Case and BRG, Wayne chats with Bethany Hills, Partner at White & Case's New York offi…
4 months, 1 week ago
FDA's Regulatory Revisions: Business & Legal Impact on Industry, Part 4 – Consumer Products
Season 1 Episode 43
In the final part of our series in collaboration with Skadden, Wayne chats with Rachel Turow, Head of Skadden's Regulatory Practice; Amy Van Gelder,…
4 months, 2 weeks ago
Breaking Down FDA's Proposed FY27 Budget
Episode 12
Wayne chats with Dr. Cartier Esham, CEO of Esham Strategies and Executive Director of the Alliance for a Stronger FDA. Together, they discuss FDA's …
4 months, 2 weeks ago
What's Next for Cosmetics and Personal Care Products?
Season 1 Episode 42
Wayne chats with Jessica O'Connell, Partner at Covington and Co-Chair of the firm's Food, Drug, and Device Practice Group; and Rebecca Dandeker, Part…
4 months, 3 weeks ago
A Fresh Look at the State of Human Foods
Season 1 Episode 41
Wayne chats with Brian Sylvester, Partner in Morrison Foerster's FDA and Healthcare Regulatory and Compliance Group, and Scott Faber, Senior Vice Pr…
4 months, 4 weeks ago
Where Does FDA Go From Here?
Episode 11
Wayne chats with Paul Kim, Principal of Kendall Square Policy Strategies LLC, and Stuart Pape, Senior Partner and Food and Drug Chair at Polsinelli. …
5 months ago
Insights on Evidence and Communication with FDA in Device Submissions
Season 1 Episode 40
Wayne chats with Mark DuVal, CEO of DuVal & Associate; Bryan Feldhaus, President of DuVal & Associates; and Chris Lyle, Vice President of Evidence S…
5 months, 1 week ago